Number of pages: 100 | Report Format: PDF | Published date: 01 November, 2022
Historical Years – | Base Year – | Forecasted Years –
The demand for molecular quality control systems has been increasing due to the growing number of accredited clinical laboratories. This is considering the consistent growth in the chronic disease burden worldwide. There is a high need for molecular quality control systems due to the growing significance of government body accreditation for clinical laboratories performing diagnostic procedures. The relevant authorities evaluate a laboratory's quality system and competency in accordance with a set of requirements during the accreditation process. Moreover, due to advancements in technology, new multi-analyte and multi-instrument controllers have been created. Clinical laboratories can save money by using these innovative controls, which consolidate numerous instrument-specific controls into a single control. The lack of separate quality control procedures for each analyte allows for additional time savings thanks to these controls. Additionally, a few companies have expanded their portfolios of testing solutions.
The Global Molecular Quality Controls Market report presents in-depth assessment of this industry with specific focus on global and regional trends and future outlook. This report aims at providing global and regional segment analysis based on categories such as product, application, end user and geography. The study also proposes to include study of the prevalent market drivers, restraints and future opportunities on the global landscape.
Global Molecular Quality Controls Market, by Product
Global Molecular Quality Controls Market, by Application
Global Molecular Quality Controls Market, by End-User
Global Molecular Quality Controls Market, by Region
Key Market Trends
The molecular quality controls market's dominant geographical region is North America. In terms of molecular quality controls, the region is anticipated to lead the world during the anticipated time. The United States led North America in terms of revenue. The national market for molecular quality controls is anticipated to grow quickly due to the expansion of clinical labs' CLIA accreditation. Due to the well-established healthcare infrastructure, increased investments by major players in the development of cutting-edge diagnostic procedures for cancer diagnosis and infectious disease detection, the presence of major players, and the simplicity of access to technologically cutting-edge products, the molecular quality controls market is predicted to grow. The Asia Pacific molecular quality controls market will expand significantly due to the rising demand for precise and high-quality diagnostics tests. The need for precision oncology has been a major topic of concern for various authorities in the region, leading to the formation of numerous programmers. Cancer is becoming an increasingly common health issue in the APAC region because of ageing populations and changes in lifestyle.
Key Components of the Report
Key Market Players
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann La-Roche Ltd., Abbott Inc., Quidel Corporation, Seracare Life Sciences, Qnostics, Maine Molecular Controls, Inc., Zeptometrix Corporation, and Microbiologics and others.
Reasons to Buy this Report